Mount Sinai Receives $8.8 million Grant to Further Stem Cell Research
April 7, 2015
An $8.8 million grant from the New York State Stem Cell Science Program will accelerate efforts by the Icahn School of Medicine at Mount Sinai to develop new stem-cell-based treatments for chemotherapy-resistant blood cancer and other genetic blood disorders.
Icahn School of Medicine at Mount Sinai and LifeMap Solutions Launch Asthma Study for iPhone
March 9, 2015
The Icahn School of Medicine at Mount Sinai and LifeMap Solutions, a subsidiary of BioTime (BTX), today announced the launch of a large-scale medical research study that uses the new ResearchKit framework developed by Apple to make it easy for individuals who suffer from Asthma to participate in studies right from their iPhone.
Novel Drug Candidate Regenerates Pancreatic Cells Lost in Diabetes
March 9, 2015
In a screen of more than 100,000 potential drugs, only one, harmine, drove human insulin-producing beta cells to multiply, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai, funded by JDRF and the National Institutes of Health, and published online today in Nature Medicine.
Mount Sinai Launches Artificial Pancreas Research Study
January 21, 2015
A newly launched clinical research study at the Icahn School of Medicine at Mount Sinai is examining whether an artificial pancreas (AP) can prevent too low blood sugar levels or hypoglycemia in patients with type 1 diabetes (T1D) as they sleep.
Mount Sinai Scientists Gain New Insight into Hepatitis C Antiviral Resistance
November 18, 2014
Nature Communications paper offers pivotal new information about how the virus interacts with and evades therapeutics, as well as new clues to its role in cancer development
Changes in a Single Gene’s Action Can Control Addiction- and Depression-Related Behaviors
November 10, 2014
New DNA regulatory technique modifies the environment around a single gene to control gene expression and behavioral consequences
Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date
July 22, 2014
Genes and pathways identified could inform new approaches to treatment and address acute need for drug development for this disorder
Mount Sinai’s CEO Kenneth L. Davis, MD, and Icahn School of Medicine at Mount Sinai Dean Dennis S. Charney, MD, Featured at 2014 Aspen Ideas Festival June 24 - July 3
June 23, 2014
Free Skin Cancer Screenings at Mount Sinai Health Concourse
More than 200 Inquiries Received for Mount Sinai’s New Masters in Health Care Delivery Leadership Program
May 20, 2014
Application period ends August 1st; Icahn School of Medicine at Mount Sinai offers first medical school program addressing critical challenges in health care
Mount Sinai Researchers Identify Subtle Changes that May Occur in Neural Circuits Due to Cocaine Addiction
May 7, 2014
Research May Offer a Unique Pathway for Targeting New Therapeutics for Addiction Treatment
Mount Sinai Scientists Identify First Gene Linked to Heart Muscle Disease in Children
April 28, 2014
Findings show several FDA-approved drugs may also be effective in patients diagnosed with dilated cardiomyopathy.
Mount Sinai Researchers Identify Genetic Alterations in Shared Biological Pathways as Major Risk Factor for Autism Spectrum Disorder
April 24, 2014
A substantial proportion of risk for developing autism spectrum disorders (ASD), resides in genes that are part of specific, interconnected biological pathways, according to researchers from the Icahn School of Medicine at Mount Sinai.
Researchers Find Boosting Depression-Causing Mechanisms in the Brain Increases Resilience, Surprisingly
April 17, 2014
New antidepressant approach potentially promotes natural resilence, fewer side effects.
Intravenously Administered Ketamine Shown to Reduce Symptoms of Chronic Post-Traumatic Stress Disorder
April 16, 2014
Researchers from Mount Sinai demonstrate proof of concept for new, rapidly-acting pharmacotherapy for treatment of PTSD.
Erik Lium, PhD, Named Vice President of Mount Sinai Innovation Partners
March 31, 2014
Dr. Lium previously held the post of Assistant Vice Chancellor for Innovation, Technology and Alliances at the University of California, San Francisco.
Andrew Leibowitz, MD Appointed Chairman of the Department of Anesthesiology at Mount Sinai
March 27, 2014
Dr. Leibowitz succeeds David L. Reich, MD, who was recently named President and Chief Operating Officer of The Mount Sinai Hospital.
Key Heart Failure Culprit Discovered
March 12, 2014
Collaborative research study shows blocking microRNA miR-25 halts progression of heart failure, improves cardiac function, and may increase survival.
Discovery of Root Cause of Triple-Negative Breast Cancer May Lead to New Therapies
March 5, 2014
TNBC comprises about 15-20 percent of all breast cancer diagnoses; disproportionately affects women of African and Hispanic descent.
Mount Sinai Study Points to New Biological Mechanisms, Treatment Paradigm for Kidney Disease
March 3, 2014
Drug research and development should target cell-cell interactions that promote disease progression.
Hypnosis Therapy Shown to Decrease Fatigue Levels In Breast Cancer Patients
February 20, 2014
Researchers at Mount Sinai find cognitive behavioral therapy plus hypnosis (CBTH) reduces fatigue in radiotherapy breast cancer patients
Mount Sinai Genetic Testing Laboratory Launches More Accurate Carrier Screening Test for Spinal Muscular Atrophy
February 11, 2014
Use of genetic variants improves detection of SMA carriers in clinical test that will be broadly licensed to testing labs worldwide.
Engineered Cardiac Tissue Developed to Study the Human Heart
February 2, 2014
Researchers show their human engineered cardiac tissue may provide a reliable surrogate for human myocardium to improve preclinical therapeutic testing.
With Large-Scale New Studies, Mount Sinai Scientists Help Underscore the Genetic Complexity in Schizophrenia
January 22, 2014
Largest exome studies of schizophrenia to date establish critical new scientific resources for biomedical community and the possibility of more tailored treatment for patients.
Graduate Program in Public Health at Mount Sinai Joins Association of Schools and Programs of Public Health
August 14, 2013
ASPPH connects public health schools and programs accredited by the Council on Education for Public Health.
Blocking Sugar Intake May Reduce Cancer Risk or Progression in Obese and Diabetic People
August 1, 2013
Findings reveal why patients with metabolism-related diseases are at higher risk for aggressive tumors
Inhibiting Enzymes in the Cell May Lead to Development and Proliferation of Cancer Cells
April 25, 2013
Blocking certain enzymes in the cell may prevent cancer cell division and growth, according to new findings from researchers at Mount Sinai
Ramon Parsons, MD, PhD, Named Chair of Oncological Sciences at the Icahn School of Medicine at Mount Sinai
March 6, 2013
Stuart Aaronson, MD, will continue conducting transformative research at Mount Sinai as Founding Chair, Emeritus
Protein Lost in Tumors Blocks Normal Cells From Being Reprogrammed into Stem Cells
March 5, 2013
Mount Sinai researchers identify mechanism that prevents cells from being reprogrammed into embryonic stem cells
Mount Sinai Researchers Identify Promising Drug Target for Depression
February 17, 2013
Decreased expression of a protein called Rac1 may be a primary cause of depression, according to a new study in human and mouse brains.
Sugar Consumption Increases Risk of Heart Disease
January 18, 2013
First fruit fly model of diet-induced type 2 diabetes shows how high-sugar diet affects the heart and reveals new therapeutic opportunities
Mount Sinai School of Medicine Researchers Awarded “Provocative Questions” Grant from National Cancer Institute
September 20, 2012
Researchers are among a select group of scientists who have been recognized for their quest to answer the most pressing questions about cancer.